Trade AbbVie ^ABBV

AbbVie Inc. $ABBV Shares Acquired by Curi Capital LLC - Markets Daily

AbbVie Inc. $ABBV Shares Acquired by BI Asset Management Fondsmaeglerselskab A S

Pharmaceutical Stocks To Follow Today - December 10th - Stock Observer

Ameriprise Financial Inc. Sells 3,127,890 Shares of AbbVie Inc. $ABBV

Adage Capital Partners GP L.L.C. Lowers Position in AbbVie Inc. $ABBV

Engineers Gate Manager LP Increases Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Raised to Strong-Buy at Wall Street Zen

BRITISH COLUMBIA INVESTMENT MANAGEMENT Corp Sells 59,257 Shares of AbbVie Inc. $ABBV - Daily Political

BBR Partners LLC Sells 4,280 Shares of AbbVie Inc. $ABBV - Daily Political

Bellevue Group AG Boosts Stock Position in AbbVie Inc. $ABBV - Daily Political

Peapack Gladstone Financial Corp Buys 20,164 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie Inc. $ABBV Shares Bought by Quantinno Capital Management LP

Hamilton Capital LLC Cuts Holdings in AbbVie Inc. $ABBV

Alliancebernstein L.P. Increases Stake in AbbVie Inc. $ABBV

Peapack Gladstone Financial Corp Acquires 20,164 Shares of AbbVie Inc. $ABBV - Stock Observer

Diversify Advisory Services LLC Buys 10,883 Shares of AbbVie Inc. $ABBV - Daily Political

Why AbbVie, Pfizer and Medtronic appeal to dividend investors

CIBC Asset Management Inc Has $59.11 Million Stock Holdings in AbbVie Inc. $ABBV - Markets Daily

The Manufacturers Life Insurance Company Grows Stock Position in AbbVie Inc. $ABBV - Stock Observer

HSBC Upgrades AbbVie (ABBV) to Buy, Raises Price Target to $265

AbbVie (NYSE:ABBV) Raised to "Strong-Buy" at Hsbc Global Res - Daily Political

This Dividend Pharma Giant Yielding 2.9% Just Got a Big Vote of Confidence

HSBC highlights one pharma stock to buy and one to sell for 2026

AbbVie Inc. $ABBV Shares Sold by Integrated Investment Consultants LLC

Gamco Investors INC. ET AL Grows Stock Holdings in AbbVie Inc. $ABBV - Stock Observer

NewEdge Advisors LLC Has $103.13 Million Stake in AbbVie Inc. $ABBV - Daily Political

Botox brand struggles amid natural aging movement

Medincell Publishes its Consolidated Half-Year Financial Results

AbbVie Inc. $ABBV Shares Bought by State Street Corp

Daiwa Securities Group Inc. Buys 38,862 Shares of AbbVie Inc. $ABBV

Medical Aesthetic Devices Market Projected to Reach $37.9 Billion by 2029

Tripletail Wealth Management LLC Acquires New Holdings in AbbVie Inc. $ABBV - Daily Political

Certuity LLC Sells 2,442 Shares of AbbVie Inc. $ABBV - Stock Observer

AbbVie (NYSE:ABBV) Shares Down 1.4% - Here's Why

Genmab Announces New Data from Phase 1b/2 EPCORE® CLL-1 Highlighting Potential of Epcoritamab as Monotherapy and in Combination for Patients with Richter Transformation (RT) | Taiwan News | Dec. 9, 2025 05:30

SVB Wealth LLC Sells 113,330 Shares of AbbVie Inc. $ABBV

Ossiam Has $51.75 Million Holdings in AbbVie Inc. $ABBV

Gabelli Funds LLC Cuts Stock Holdings in AbbVie Inc. $ABBV

AbbVie Inc. (NYSE:ABBV) Receives $241.85 Consensus Price Target from Analysts - Markets Daily

Jump Financial LLC Buys New Shares in AbbVie Inc. $ABBV - Stock Observer

OSE Immunotherapeutics Announces Strategic Amendment to AbbVie's Partnership on ABBV-230 Development | Taiwan News | Dec. 8, 2025 14:30

Ossiam Acquires 230,317 Shares of AbbVie Inc. $ABBV - Daily Political

ABBV: Future Performance Will Depend On Extended Exclusivity And Pipeline Execution

Genmab Presents Pivotal Phase 3 Data from EPCORE® FL-1 Trial Demonstrating Clinical Benefit of EPKINLY® (epcoritamab-bysp) in Combination with Rituximab and Lenalidomide (R2) in Patients with Relapsed or Refractory Follicular Lymphoma

Federated Hermes Inc. Acquires 134,942 Shares of AbbVie Inc. $ABBV

Cerity Partners LLC Has $210.15 Million Holdings in AbbVie Inc. $ABBV

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) | Taiwan News | Dec. 6, 2025 22:30

SageView Advisory Group LLC Increases Stock Position in AbbVie Inc. $ABBV - Markets Daily

SageView Advisory Group LLC Acquires 4,020 Shares of AbbVie Inc. $ABBV - Stock Observer

Is AbbVie's Expanding Migraine And Oncology Pipeline Reshaping The Investment Case For AbbVie (ABBV)?

StoneX Group Inc. Has $8.75 Million Stake in AbbVie Inc. $ABBV - Daily Political

Brokerages Set AbbVie Inc. (NYSE:ABBV) Target Price at $241.85 - Stock Observer

Genmab Announces Data From Multiple Clinical Trials Showing Treatment with Fixed-Duration Epcoritamab Led to Remissions in First-Line Diffuse Large B-Cell Lymphoma (DLBCL) and Follicular Lymphoma (FL) | Valuespectrum.com

AbbVie (NYSE:ABBV) Shares Down 1.1% - What's Next?

Marshall Wace LLP Grows Stake in AbbVie Inc. $ABBV

M Holdings Securities Inc. Increases Holdings in AbbVie Inc. $ABBV

Quantbot Technologies LP Takes Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Position Lifted by Epoch Investment Partners Inc.

AbbVie Inc. $ABBV Shares Purchased by Cresset Asset Management LLC - Daily Political

Kennedy Capital Management LLC Reduces Holdings in AbbVie Inc. $ABBV

First Trust Advisors LP Trims Stake in AbbVie Inc. $ABBV

Groupe la Francaise Purchases 6,466 Shares of AbbVie Inc. $ABBV

Baird Financial Group Inc. Sells 36,202 Shares of AbbVie Inc. $ABBV

Kennedy Capital Management LLC Lowers Stake in AbbVie Inc. $ABBV - Stock Observer

Best Pharmaceutical Stocks To Keep An Eye On - December 1st - Stock Observer

Assessing AbbVie's (ABBV) Valuation After New Cancer Data, EPKINLY Approval, and Dividend Hike

AbbVie (NYSE:ABBV) Shares Up 2.6% - What's Next?

AbbVie (NYSE:ABBV) Trading 2.6% Higher - Time to Buy? - Daily Political

Invesco Ltd. Lowers Stock Holdings in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Bought by CW Advisors LLC

AbbVie Inc. (NYSE:ABBV) Receives Average Rating of "Moderate Buy" from Analysts

Is It Too Late to Consider AbbVie After Its Strong Multi Year Share Price Rally?

Non-small cell lung cancer molecular subtypes and vulnerability to immunotherapy treatment combinations

Is AbbVie Stock Set for More Gains After 25% Rally and Product Launches?

AbbVie (NYSE:ABBV) Is Increasing Its Dividend To $1.73

Portfolio Design Labs LLC Sells 4,734 Shares of AbbVie Inc. $ABBV - Markets Daily

AbbVie to Feature New Data at ASH 2025 Showcasing Continued Advances Across Novel Treatment Modalities in Multiple Blood Cancers

Portfolio Design Labs LLC Has $571,000 Stake in AbbVie Inc. $ABBV

Loomis Sayles & Co. L P Purchases 18,866 Shares of AbbVie Inc. $ABBV

AbbVie Inc. $ABBV Shares Sold by Fisher Asset Management LLC

FDA Approves Amneal Pharma's Generic Equivalent Of RESTASIS For Dry Eye Disease

Pharma company of the year award for AbbVie

Correction: Machine learning reveals limited predictive value of clinical factors for asthma exacerbations

AbbVie (NYSE:ABBV) Stock Price Down 1.3% - Here's What Happened

Sepio Capital LP Has $38.93 Million Position in AbbVie Inc. $ABBV

AbbVie Inc. $ABBV is Distillate Capital Partners LLC's 4th Largest Position

AbbVie Inc. $ABBV Shares Purchased by Everstar Asset Management LLC

Smith Moore & CO. Lowers Holdings in AbbVie Inc. $ABBV - Stock Observer

Claret Asset Management Corp Trims Stock Holdings in AbbVie Inc. $ABBV - Daily Political

AbbVie Inc. $ABBV Shares Bought by VestGen Advisors LLC

Railway Pension Investments Ltd Lowers Position in AbbVie Inc. $ABBV

Northwestern Mutual Wealth Management Co. Grows Position in AbbVie Inc. $ABBV - Markets Daily

Wall Street Zen Downgrades AbbVie (NYSE:ABBV) to Buy